Gerald Berry

Dr. Lawrence “Rusty” Hofmann is an actively practicing physician and Professor of Interventional Radiology at Stanford School of Medicine, as well as the Chief of Industry Partnerships for Stanford Healthcare, Medical Director of Cardiac and Interventional Services, and the Medical Director of Digital Health at Stanford Medicine. He served as Chief of Interventional Radiology at Stanford for nearly two decades. He is the Co-Founder of Grand Rounds, Inc, rebranded as Included Health. He has devoted his career to providing state-of-the-art care to patients at either Johns Hopkins, where he practiced for 10 years, or Stanford, where he practiced for 15 years.

Caroline Berube, MD, is a highly qualified hematologist-oncologist and clinical professor at Stanford University, specializing in the treatment of various blood disorders and cancers. With extensive training and multiple board certifications, Dr. Berube has contributed significantly to the field through research and publications, focusing on innovative therapies and patient care. Dr. Berube's educational background includes fellowships at prestigious Canadian institutions and a medical degree from Laval University. She currently serves as the Medical Director of the Oral Anticoagulation Clinic at Stanford Hospital and Clinics, where she applies her expertise to improve patient outcomes in hematology and oncology. Generated from the website

Dr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor.